Critical Element | Percent Reporting | 95% Confidence Interval |
---|---|---|
Description of Patient and Disease | ||
Age and gender | 99 | 95 – 100 |
Definition, severity and stage of disease | 88.1 | 79 – 93 |
Co-Morbid conditions | 45.2 | 35 – 56 |
Patient medications | 29.7 | 21 – 40 |
Description of Interventions | ||
Route or dose of medications or details of procedure described | 79.7 | 70 – 87 |
Co-interventions | 57.1 | 46 – 67 |
Description of Outcomes | ||
Clinically relevant outcomes defined | 90.4 | 82 – 95 |
Side effects reported | 33.3 | 24 – 44 |
Threats to Generalizability anad Validity | ||
Generalizability | 28.6 | 20 – 39 |
Alternative explanations | 27.4 | 19 – 38 |
Information about denominator | 2.3 | 1 – 8 |